Search results
Results from the Health.Zone Content Network
The Biomedical Advanced Research and Development Authority ( BARDA )' is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza ...
The Stockholm School of Economics ( SSE; Swedish: Handelshögskolan i Stockholm, HHS) is a private business school located in city district Vasastaden in the central part of Stockholm, Sweden. SSE offers BSc, MSc and MBA programs, along with PhD - and Executive education programs. [3] SSE is accredited by EQUIS and is a member of CEMS.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
x. AOL works best with the latest versions of the browsers. You're using an outdated or unsupported browser and some AOL features may not work properly.
Non-profit. Headquarters. Ann Arbor, Michigan. Website. www .hl7 .org. Health Level Seven International ( HL7) is a non-profit ANSI -accredited standards development organization that develops standards that provide for global health data interoperability . The 2.x versions of the standards are the most commonly used in the world.
Origins. It is built by the Internal Revenue Service (IRS) and Health and Human Services (HHS). It combines data on income and employment from IRS records, health and entitlements from HHS records, identity from Social Security, citizenship from Department of Homeland Security records, criminality from Department of Justice records, and residency from state records.
Startup accelerator. Startup accelerators, also known as seed accelerators, are fixed-term, cohort-based programs, that include mentorship and educational components, and culminate in a public pitch event or demo day. [1] While traditional business incubators are often government-funded, generally take no equity, and rarely provide funding ...
t. e. The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. [1]